How Collaboration Is Driving the Next Wave of Genomics

Illumina’s Open Innovation programs work with partners to change lives

SOURCE: Illumina

DESCRIPTION:

BY FASTCO WORKS​

RESHAPING MEDICINE

Illumina’s advances in genetic sequencing are reshaping medicine. Genetic sequencing has now allowed cancer patients to find treatment options specific to their tumors, doctors to anticipate adverse drug reactions and personalize medicine, public health agencies around the world to track and detect new COVID variants, and patients with rare diseases to more easily identify and treat their illnesses.

A NETWORK OF INNOVATION

Through Illumina Open Innovation, Illumina is investing in new startups and partnering in research efforts to develop solutions in areas such as rapid sequencing and data security. “To really unlock the power of the genome is something we can’t do alone,” Van Zeeland says.

Read the full article here

Learn more about Illumina here

Tweet me: Learn about @illumina's Open Innovation program and how investments in new startups can create opportunities and innovations that are unlocking the power of the genome and ultimately reshaping medicine. Read the full story here: https://bit.ly/3xQxhoP

KEYWORDS: NASDAQ: ILMN, illumina, genomics, Genetic Sequencing, Cancer patients, Illumina Open Innovation, Ashley Van Zeeland